Liminatus Pharma, Inc.
Biotechnology company · Cerritos, California, United States · Nasdaq: LIMN
Liminatus Pharma, Inc. is a biotechnology company headquartered in Cerritos, California, United States. Its shares trade on Nasdaq under the ticker LIMN. It has reported private securities offerings to the US SEC, most recently $1.9 million sold in a notice filed in 2026.
Liminatus Pharma at a glance
What does Liminatus Pharma do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $1.9 million sold (2026).
Frequently asked questions about Liminatus Pharma
Where is Liminatus Pharma headquartered?
Liminatus Pharma, Inc. is headquartered in Cerritos, California, United States.
What does Liminatus Pharma do?
Liminatus Pharma, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Liminatus Pharma a public company?
Yes. Liminatus Pharma, Inc. trades on Nasdaq under the ticker LIMN.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences